BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31940169)

  • 1. Multifunctional Nanoparticles for Multimodal Imaging-Guided Low-Intensity Focused Ultrasound/Immunosynergistic Retinoblastoma Therapy.
    Wang M; Yang Q; Li M; Zou H; Wang Z; Ran H; Zheng Y; Jian J; Zhou Y; Luo Y; Ran Y; Jiang S; Zhou X
    ACS Appl Mater Interfaces; 2020 Feb; 12(5):5642-5657. PubMed ID: 31940169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-intensity focused ultrasound (LIFU)-activated nanodroplets as a theranostic agent for noninvasive cancer molecular imaging and drug delivery.
    Liu J; Xu F; Huang J; Xu J; Liu Y; Yao Y; Ao M; Li A; Hao L; Cao Y; Hu Z; Ran H; Wang Z; Li P
    Biomater Sci; 2018 Nov; 6(11):2838-2849. PubMed ID: 30229771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A laser-activated multifunctional targeted nanoagent for imaging and gene therapy in a mouse xenograft model with retinoblastoma Y79 cells.
    Wu M; Xiong H; Zou H; Li M; Li P; Zhou Y; Xu Y; Jian J; Liu F; Zhao H; Wang Z; Zhou X
    Acta Biomater; 2018 Apr; 70():211-226. PubMed ID: 29452275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
    Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
    Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
    [No Abstract]   [Full Text] [Related]  

  • 5. Low intensity focused ultrasound (LIFU) triggered drug release from cetuximab-conjugated phase-changeable nanoparticles for precision theranostics against anaplastic thyroid carcinoma.
    Wang Y; Sui G; Teng D; Wang Q; Qu J; Zhu L; Ran H; Wang Z; Jin C; Wang H
    Biomater Sci; 2018 Dec; 7(1):196-210. PubMed ID: 30422139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted and pH-facilitated theranostic of orthotopic gastric cancer via phase-transformation doxorubicin-encapsulated nanoparticles enhanced by low-intensity focused ultrasound (LIFU) with reduced side effect.
    Liu Z; Ran H; Wang Z; Zhou S; Wang Y
    Int J Nanomedicine; 2019; 14():7627-7642. PubMed ID: 31571868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-Target Multifunctional Superparamagnetic Cationic Nanoliposomes for Multimodal Imaging-Guided Synergistic Photothermal/Photodynamic Therapy of Retinoblastoma.
    Zheng W; Li X; Zou H; Xu Y; Li P; Zhou X; Wu M
    Int J Nanomedicine; 2022; 17():3217-3237. PubMed ID: 35924259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nanosystem loaded with perfluorohexane and rose bengal coupled upconversion nanoparticles for multimodal imaging and synergetic chemo-photodynamic therapy of cancer.
    Wang HY; Hou L; Li HL; Wang X; Cao Y; Zhang BY; Wang JT; Wei SJ; Dang HW; Ran HT
    Biomater Sci; 2020 May; 8(9):2488-2506. PubMed ID: 32211626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional liposome for photoacoustic/ultrasound imaging-guided chemo/photothermal retinoblastoma therapy.
    Li M; Bian X; Chen X; Fan N; Zou H; Bao Y; Zhou Y
    Drug Deliv; 2022 Dec; 29(1):519-533. PubMed ID: 35156504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Laser-Activated Biocompatible Theranostic Nanoagent for Targeted Multimodal Imaging and Photothermal Therapy.
    Deng L; Cai X; Sheng D; Yang Y; Strohm EM; Wang Z; Ran H; Wang D; Zheng Y; Li P; Shang T; Ling Y; Wang F; Sun Y
    Theranostics; 2017; 7(18):4410-4423. PubMed ID: 29158836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanosonosensitizers for Highly Efficient Sonodynamic Cancer Theranostics.
    Huang J; Liu F; Han X; Zhang L; Hu Z; Jiang Q; Wang Z; Ran H; Wang D; Li P
    Theranostics; 2018; 8(22):6178-6194. PubMed ID: 30613291
    [No Abstract]   [Full Text] [Related]  

  • 12. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
    Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
    Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Multifunctional Theranostic Nanoagent for Dual-Mode Image-Guided HIFU/Chemo- Synergistic Cancer Therapy.
    Zhang N; Cai X; Gao W; Wang R; Xu C; Yao Y; Hao L; Sheng D; Chen H; Wang Z; Zheng Y
    Theranostics; 2016; 6(3):404-17. PubMed ID: 26909114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-Loaded Acoustic Nanodroplet for Dual-Imaging Guided Highly Efficient Chemotherapy Against Nasopharyngeal Carcinoma.
    Yang D; Chen Q; Zhang M; Feng G; Sun D; Lin L; Jing X
    Int J Nanomedicine; 2022; 17():4879-4894. PubMed ID: 36262190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication of doxorubicin-gated mesoporous polydopamine nanoplatforms for multimode imaging-guided synergistic chemophotothermal therapy of tumors.
    Yang M; Zhang N; Zhang T; Yin X; Shen J
    Drug Deliv; 2020 Dec; 27(1):367-377. PubMed ID: 32091284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase-shift, targeted nanoparticles for ultrasound molecular imaging by low intensity focused ultrasound irradiation.
    Li M; Luo H; Zhang W; He K; Chen Y; Liu J; Chen J; Wang D; Hao L; Ran H; Zheng Y; Wang Z; Li P
    Int J Nanomedicine; 2018; 13():3907-3920. PubMed ID: 30013344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional nanotheranostic gold nanocages for photoacoustic imaging guided radio/photodynamic/photothermal synergistic therapy.
    Xu X; Chong Y; Liu X; Fu H; Yu C; Huang J; Zhang Z
    Acta Biomater; 2019 Jan; 84():328-338. PubMed ID: 30500447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fe
    Li Y; Zhang H
    Nanomedicine (Lond); 2019 Jun; 14(11):1493-1512. PubMed ID: 31215317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theranostic Nanoplatform with Sequential SDT and ADV Effects in Response to Well-Programmed LIFU Irradiation for Cervical Cancer.
    Zhou J; Hou J; Liu S; Xu J; Luo Y; Zheng J; Li X; Wang Z; Ran H; Guo D
    Int J Nanomedicine; 2021; 16():7995-8012. PubMed ID: 34916791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "All-in-One" Silver Nanoprism Platform for Targeted Tumor Theranostics.
    Zeng X; Yan S; Di C; Lei M; Chen P; Du W; Jin Y; Liu BF
    ACS Appl Mater Interfaces; 2020 Mar; 12(10):11329-11340. PubMed ID: 32072808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.